Effect of laser photocoagulation treatment for diabetic macular oedema on patient's vision-related quality of life

Current Eye Research

Volumn 29, Issue 1, 2004, Pages 41-49

  Tranos, Paris G ^a,d   Topouzis, F ^b   Stangos, N T ^b   Dimitrakos, S ^b   Economidis, P ^b   Harris, M ^a   Coleman, A L ^c  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Diabetic retinopathy; Laser photocoagulation; Macular oedema; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; FEMALE; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL VISION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK FACTOR; TREATMENT INDICATION; TREATMENT OUTCOME; VISION; VISUAL ACUITY; WELLBEING;

AGED; DIABETIC RETINOPATHY; FEMALE; HEALTH STATUS; HUMANS; LASER COAGULATION; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; VISUAL ACUITY;

EID: 6344243209     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680490513191     Document Type: Article

References (18)

1. Hamilton AMP, Ulbig MW, Polkinghorne P. Management of diabetic retinopathy. London, BMJ Publishing Group, 1996:1.
2. Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular oedema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985;103:1796-1806.
3. Early Treatment Diabetic Retinopathy Study Research Group: Treatment techniques and clinical guidelines for photocoagulation of diabetic macular oedema: Early Treatment Diabetic Retinopathy Study report number 2. Ophthalmology. 1987;94:761-774.
4. Early Treatment Diabetic Retinopathy Study Research Group: Case reports to accompany Early Treatment Diabetic Retinopathy Study reports 3 and 4. Int Ophthalmol Clin. 1987;27:273-333.
5. Gutierrez P, Wilson MR, Johnson C, Gordon M, Cioffi GA, Ritch R, Sherwood M, Meng K, Mangione CM. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 1997 Jun;115(6):777-784.
6. Parrish RK 2nd, Gedde SJ, Scott IU, Feuer WJ, Schiffman JC, Mangione CM, Montenegro-Piniella A. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997 Nov;115(11):1447-1455.
7. Nelson P, Aspinall P, O'Brien C. Patients' perception of visual impairment in glaucoma: A pilot study. Br J Ophthalmol. 1999 May;83(5):546-552.
8. Scott IU, Schein OD, West S, Bandeen-Roche K, Enger C, Folstein MF. Functional status and quality of life measurement among ophthalmic patients. Arch Ophthalmol. 1994 Mar;112(3):329-335.
9. Mangione CM, Gutierrez PR, Lowe G, Orav EJ, Seddon JM. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol. 1999 Jul;128(1):45-53.
10. Mangione CM, Berry S, Spritzer K, Janz NK, Klein R, Owsley C, Lee PP. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: Results from focus groups with visually impaired persons. Arch Ophthalmol. 1998;116(2):227-233.
11. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators: Arch Ophthalmol. 1998;116(11): 1496-1504.
12. Early Treatment Diabetic Retinopathy Study Research Group. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics: ETDRS report number 7. Ophthalmology. 1991;98:741-756.
13. Folstein MF, Folstein SE, McHugh PR. The Mini-Mental State: A practical method for grating the cognitive state of patients for the clinicians. J Psychiatr Res. 1975;12: 189-198.
14. Klein R, Klein BEK, Moss SE. Visual impairment in diabetes. Ophthalmology. 1984;91:1-9.
15. Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, Friend J, McCarthy D, Wu SY. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993 Jun;111(6):831-836.
16. Olk RJ. Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular oedema. Ophthalmology. 1986 Jul;93(7):938-950.
17. Olk RJ. Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular oedema. Ophthalmology. 1990 Sep;97(9):1101-1112.
18. Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular oedema. Long-term visual results. Ophthalmology. 1991 Oct;98(10):1594-1602.